Skip to content

Beetroot Juice - Effects on Performance in Chronic Obstructive Pulmonary Disease Patients

Beetroot Juice - Effects on Performance in Chronic Obstructive Pulmonary Disease Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03020862
Acronym
COPD
Enrollment
15
Registered
2017-01-13
Start date
2013-12-31
Completion date
2015-08-31
Last updated
2017-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease Moderate

Keywords

Dietary nitrate, Physical performance, Blood pressure, Nitrite, Exercise

Brief summary

The purpose is to evaluate exercise performance in patients with Chronic Obstructive Pulmonary Disease (COPD) after supplementing with higher doses of dietary NO3-, compared to previous studies, as beetroot juice for seven days. The secondary purpose is to evaluate oxygen consumption of submaximal cycling, amendments in blood pressure, and physical activity level.

Detailed description

The purpose is to evaluate exercise performance in patients with Chronic Obstructive Pulmonary Disease (COPD) using the 6-minute walk test (6MWT) after supplementing with higher doses of dietary NO3- compared to previous studies, as beetroot juice for seven days. The secondary purpose is to evaluate oxygen consumption of submaximal cycling, amendments in blood pressure, and physical activity level.

Interventions

DIETARY_SUPPLEMENTDietary beetroot juice

Consumed as concentrated beetroot juice from James White Drinks England (Beet-it) and contained 300 mg dietary nitrate. Dose: 2x70 mL consumed twice a day for six days.

Sponsors

University of Aarhus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Moderate-severe Chronics Obstructive Pulmonary Disease (COPD) (FEV1 \<80% of predicted).

Exclusion criteria

* Smoking, * failure to complete physical testing, * on-going participation in rehabilitation programs, * pacemaker or use of nicotine products, * oxygen mask, * beta blockers, * antibacterial mouthwash, * chewing gum or stomach-neutralizing medicine during the intervention.

Design outcomes

Primary

MeasureTime frame
Physical performance on 6-min walk test (6MWT)6 minutes

Secondary

MeasureTime frameDescription
Blood PressureAt baseline and 150 minutes after consumption of beverages
Plasma Nitrite concentrationBaseline, 150 and 210 minutes after consumption of beverages
Oxygen consumption during submaximal cyclingTwo trials of 6 minutes duration (10 min break between trials)
Physical activity levelSix daysMeasured all intervention days except on the day of testing

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026